HOME >> BIOLOGY >> NEWS
Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find

A team of scientists from Johns Hopkins Children's Center and two other institutions have found that low levels of HIV-1 virus in the blood of children and adults undergoing a common combination drug therapy does not necessarily indicate the virus is becoming resistant to these life-prolonging medications.

In the first study to show a low level of viral activity in children using the therapy, called HAART (highly active anti-retroviral therapy), a team led by Children's Center infectious disease researcher Deborah Persaud, M.D., says that bloodstream signatures of HIV-1 revealed no genetic signs that the virus was developing resistance. The finding, published in this week's Journal of the American Medical Association, has implications for the design and future treatment strategies in fighting the onset of AIDS.

"Going into the study, we thought it was possible that even low levels of virus activity could result in the evolution of resistance to HAART drugs," Persaud says. "But both the children and adults in our study showed that the therapy is working."

The report also shows that occasional increases in apparent virus activity, called "blips," do not necessarily indicate the virus is resisting the protease inhibitors and anti-retroviral drugs that make up HAART.

From the blood samples of 20 study participants, all of whom had been on HAART at least 25 months, the research team looked for the unique genetic signature left by very low levels of HIV-1, a virus that inserts itself into the human genome and begins replicating as though it were any other set of human genes.

The researchers compared each viral genetic sequence to other viral sequences from the same patient, to other patients' viral sequences and to sequences that represent drug-resistant viruses. The researchers found that viral replication and mutation had remained suppressed by HAART. Two of the 20 study participants, who responded less than optimally to HAART
'"/>

Contact: David Bricker
dbricker@jhmi.edu
410-223-1728
Johns Hopkins Medical Institutions
10-Jul-2001


Page: 1 2

Related biology news :

1. 1st International Conference on Cell Therapy for Cardiovascular Disease
2. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
3. Braunschweig Prize 2003 for Molecular Cancer Therapy
4. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
5. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
6. Invitation To Cover: American Society Of Gene Therapy Meeting
7. Gene Therapy For Pain
8. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
9. Shock Therapy Exceeds Expectations In Cleaning Up Contaminated Soils
10. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant
11. University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem ... trial for stem cell treatment of knee osteoarthritis . The successful enrollment comes only ... of VetStem Biopharma. , PSC CEO, Michael Dale, stated, “We are proud that as ...
(Date:9/30/2019)... ... September 30, 2019 , ... ... leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today ... related to “Ready-to-Print” (RTP) cellular product formats (patent number AU 2015259373). This ...
(Date:9/25/2019)... , ... September 25, 2019 , ... Deep Science ... Cancer Research UK, the world’s largest independent funder of cancer research. , Deep Science ... that takes a systems-level view of the opportunity from the start, both at the ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... As World ... middle school and high school students have improved neuro-cognitive executive skills to enhance ... physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, due to ...
(Date:10/8/2019)... ... 08, 2019 , ... As Keck Graduate Institute (KGI) students ... executives with a set of recommendations to enhance supply chain processes. Now the ... TMP to a wider audience of industry leaders attending the 12th Annual Bio ...
(Date:10/3/2019)... , ... October 01, 2019 , ... ... relax and reset itself, announced the midway point of its randomized research trial ... the study is to measure the efficacy of a non-invasive technology which compares ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... business opportunity to investors and venture capital companies in Silicon Valley at a special ... 8:30 pm. The event will be held at the JJ Lake Business Center located ...
Breaking Biology Technology:
Cached News: